Chia C. Portera

Cardiac Toxicity and Efficacy of Trastuzumab Combined with Pertuzumab in Patients with Trastuzumab-Insensitive Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Chia C. Portera, Janice M. Walshe, Douglas R. Rosing et al. · Clinical Cancer Research · 2008 · 156 citations · Full text

A Phase 1B Study of Dulanermin in Combination With Modified FOLFOX6 Plus Bevacizumab in Patients With Metastatic Colorectal Cancer

Zev A. Wainberg, Wells A. Messersmith, Parvin F. Peddi et al. · Clinical Colorectal Cancer · 2013 · 59 citations

Phase 1B, Oncology, Gastrointestinal Oncology +8

Learning and Confirming with Preclinical Studies: Modeling and Simulation in the Discovery of GDC-0917, an Inhibitor of Apoptosis Proteins Antagonist

Harvey Wong, Stephen E. Gould, Nageshwar Budha et al. · Drug Metabolism and Disposition · 2013 · 54 citations

Phase Ib Study of Drozitumab Combined With First-Line mFOLFOX6 Plus Bevacizumab in Patients with Metastatic Colorectal Cancer

Caio M. Rocha Lima, Soley Bayraktar, Aurea M. Flores et al. · Cancer Investigation · 2012 · 46 citations

Phase Ib Study, Dose Level, Advanced Recurrent +12

A Phase I Dose-Escalation Study Evaluating the Safety Tolerability and Pharmacokinetics of CUDC-427, a Potent, Oral, Monovalent IAP Antagonist, in Patients with Refractory Solid Tumors

Anthony W. Tolcher, Johanna C. Bendell, Kyriakos P. Papadopoulos et al. · Clinical Cancer Research · 2016 · 31 citations · Full text